Diana L Anderson1. Show Affiliations » 1. D.L. International, Dallas, TX, USA. danderson@rri.net
Abstract
Entities: Disease Gene
Mesh： See more » AdalimumabAntibodies, Monoclonal/immunologyAntibodies, Monoclonal/therapeutic useAntibodies, Monoclonal, HumanizedAntirheumatic Agents/immunologyAntirheumatic Agents/therapeutic useArthritis, Rheumatoid/diagnosisArthritis, Rheumatoid/drug therapyArthritis, Rheumatoid/immunologyDisease ProgressionDrug Administration ScheduleDrug Information ServicesDrug Monitoring/methodsDrug Therapy, CombinationEtanerceptHumansImmunoglobulin G/immunologyImmunoglobulin G/therapeutic useInflammationInfliximabNurse's RolePatient Education as TopicReceptors, Tumor Necrosis Factor/immunologyReceptors, Tumor Necrosis Factor/therapeutic useTreatment OutcomeTumor Necrosis Factor-alpha/antagonists & inhibitorsTumor Necrosis Factor-alpha/immunology
Substances： See more » Antibodies, MonoclonalAntibodies, Monoclonal, HumanizedAntirheumatic AgentsImmunoglobulin GReceptors, Tumor Necrosis FactorTumor Necrosis Factor-alphaInfliximabAdalimumabEtanercept
Year: 2004 PMID： 14767382 DOI： 10.1097/00000446-200402000-00023
Source DB: PubMed Journal: Am J Nurs ISSN： 0002-936X Impact factor: 2.220